The short answer to that is that the entire cost of R&D needs to be factored into the sale price. Ergo, the more you sell the less each unit needs to cover. We're talking many millions of dollars though so a reasonable chunk would need to be recovered ultimately. Sales is the only positive line on a P&L statement - all the rest (more or less) are negatives...
The short answer to that is that the entire cost of R&D needs to...
Add AKP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.20 |
Change
0.000(0.00%) |
Mkt cap ! $181.1M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| AKP (ASX) Chart |
Day chart unavailable